Aiwen Yan
Overview
Explore the profile of Aiwen Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan Y, Wang W, Yan A, Zhu H, Meng Q
Toxicol In Vitro
. 2025 Feb;
104:106020.
PMID: 39947414
Cholestasis, a condition marked by bile acid accumulation in the liver and body systems, leads to liver dysfunction and cirrhosis. Currently, ursodeoxycholic acid (UDCA) and obeticholic acid (OCA) are the...
2.
Wang J, He X, Jia Z, Yan A, Xiao K, Liu S, et al.
Pharm Biol
. 2023 Dec;
62(1):33-41.
PMID: 38100532
Context: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Gefitinib is a first-line treatment for NSCLC. However, its effectiveness is hindered by the development of...
3.
Yan A, Jia Z, Qiao C, Wang M, Ding X
Int J Oncol
. 2021 Jan;
57(5):1103-1115.
PMID: 33491740
Cancer represents a severe challenge to healthcare systems and individuals worldwide. The development of multiple drug resistance is a major issue regarding cancer therapy, which can result in the progression...
4.
Jia Z, Zhang Y, Yan A, Wang M, Han Q, Wang K, et al.
Cell Death Dis
. 2020 Aug;
11(8):670.
PMID: 32820157
Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC);...
5.
Liu C, Liu Q, Yan A, Chang H, Ding Y, Tao J, et al.
Cancer Med
. 2020 Apr;
9(11):3875-3884.
PMID: 32248666
Background: Several studies have suggested that drug resistance in colon cancer patients with diabetes may be associated with long-term insulin administration, which in turn decreases the survival rate. Metformin is...
6.
Ding X, Ge L, Yan A, Ding Y, Tao J, Liu Q, et al.
Onco Targets Ther
. 2019 Dec;
12:10547-10558.
PMID: 31819534
Objective: Due to the resistance of cancer cells, chemotherapy has been severely restricted. Docosahexaenoic acid (DHA) has been broadly identified as the chemo-sensitizing agent and revertant of multidrug resistance owing...